Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
TN

Timothy Norris — 18 Patents

Pfizer: 15 patents #264 of 5,153Top 6%
OPOsi Pharmaceuticals: 4 patents #41 of 181Top 25%
New York, NY: #980 of 20,192 inventorsTop 5%
New York: #7,989 of 115,490 inventorsTop 7%
Overall (All Time): #245,716 of 4,157,543Top 6%
18 Patents All Time
Timothy Norris has been granted 18 US patents while listed as an inventor at Pfizer. The first was granted in 1998 and the most recent in April 2009. Timothy Norris ranks #245,716 of 4,157,543 US inventors in our database (top 5.9%). Patent records list Timothy Norris in New York, NY, US.

Issued Patents All Time

Showing 1–18 of 18 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
7521456 N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine mesylate anhydrate and monohydrate Douglas J. M. Allen, Jeffrey W. Raggon, Dinos P. Santafianos, Ravi M. Shanker 2009-04-21 $10,583,000
7087613 Treating abnormal cell growth with a stable polymorph of N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine hydrochloride Jeffrey W. Raggon, Richard Connell, James D. Moyer, Michael John MORIN, Shama Kajiji +3 more 2006-08-08 $20,673,000
7019009 Acyl derivatives of 5-(2-(4-(1,2 benzisothiazole-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihydro-2h-indol-2-one having neuroleptic activity Roberto Colon-Cruz 2006-03-28 $129,509,000
6900221 Stable polymorph on N-(3-ethynylphenyl)-6, 7-bis (2methoxyethoxy)-4-quinazolinamine hydrochloride, methods of production, and pharmaceutical uses thereof Jeffrey W. Raggon, Richard Connell, James D. Moyer, Michael John MORIN, Shama Kajiji +3 more 2005-05-31 $27,561,000
6753334 Preparation of sodium-hydrogen exchanger type-1 inhibitors John F. Lambert 2004-06-22 $328,983,000
6706721 N-(3-ethynylphenylamino)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine mesylate anhydrate and monohydrate Douglas J. M. Allen, Jeffrey W. Raggon, Dinos P. Santafianos, Ravi M. Shanker 2004-03-16 $18,127,000
6476040 Processes and intermediates for preparing anti-cancer compounds Dinos P. Santafianos, Richard S. Lehner 2002-11-05 $477,474,000
6359137 Process for preparing trovafloxacin acid salts Keith M. DeVries, Peter R. Rose 2002-03-19 $869,707,000
6346624 Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems Megan E. Hnatow, John F. Lambert 2002-02-12 $1,808,403,000
6344563 Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems Megan E. Hnatow, John F. Lambert 2002-02-05
6262067 Polymorphs of a crystalline azo-bicyclo 2,2,2 OCT-3-yl amine dihydrochloride and their pharmaceutical compositions Douglas J. M. Allen, Troy Anthony Appleton, Michael Gumkowski, David Joseph Muehlbauer 2001-07-17 $383,854,000
6239285 Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems Megan E. Hnatow 2001-05-29 $968,223,000
6159976 Polymorph of zopolrestat monohydrate John F. Lambert 2000-12-12 $1,597,879,000
6114531 Process for preparing quinolone and naphthyridone carboxylic acids 2000-09-05 $418,382,000
6080756 Polymorphs of the prodrug 6-N-(L-ALA-L-ALA)-trovafloxacin James McGarry, Douglas J. M. Allen 2000-06-27 $377,915,000
6066647 Zwitterionic forms of trovafloxacin Allen J. M. Douglas, David B. Joseph 2000-05-23 $415,050,000
5929240 Process and intermediates for preparing naphthyridonecarboxylic acid salts Tamim F. Braish, Darrell E. Fox, Peter R. Rose 1999-07-27 $959,191,000
5763454 Crystal form of anhydrous 7-(1.alpha.,5.alpha.,6.alpha.!-6-amino-3-azabicyclo3.1.0!hex-3-yl)-6-f luoro-1-(2,4-difluorophenyl)-1,4-dihydro-4-oxo-1,8 naphthyridine-3-carboxylic acid, methanessulfonic acid salt Lynne A. Handanyan, Thomas A. Morris, Robert L. Hendrickson, Phillip J. Johnson 1998-06-09 $336,309,000